TDRR Recap

On July 15th, the Office of Technology Development hosted its fifth annual networking event, Tech, Drugs, and Rock n’ Roll (TDRR), from 4-8pm at Boston University. Registration for the conference opened on May 1st.

TDRR is a networking event designed to connect scientists and engineers with entrepreneurs, investors, and innovators.  The event showcased emerging technologies from research programs in life and physical sciences, medical technologies, new ventures, and student entrepreneurship programs.

Project SearchAdditionally TDRR held its first Social Entrepreneurship award. Four student projects, hoping to impact global health, competed for a $3,000 prize. The winner was determined by attendees who texted their vote during the event.  SEARCH, a smartphone enabled with biometric identification software that can identify people by imaging their ears, won this year’s prize.

Gloria Waters (Vice President and Associate Provost for Research) announced this year’s Innovator of the Year Award (IOTY). This award recognizes entrepreneurial faculty at Boston University who have translated their research for the benefit of humankind.

The Office of Technology Development honored Mark Crovella, faculty in Computer Science this year with the Innovator of the Year award.  Congratulations Mark!

IOTY award“Professor Crovella is an entrepreneurial scientist, whose inventions have been licensed to two start-up companies,” announced   Gloria Waters.  “His accomplishments in the past year include ten peer-reviewed papers published, five patent filings and $30.0 million invested in BU-spinoff Guavus.”

The IOTY award highlights translational research with commercialization potential and broad community impact.  It encourages faculty to become entrepreneurial and role models who can inspire graduate students. Past winners of the award have been:  Mark Grinstaff (Biomedical Engineering), Avi Spira (School of Medicine), Jim Collins (Biomedical Engineering), and Ted Moustakas (Engineering).

TDRR crowd networkingProfessor Crovella is Professor and Chair of the Computer Science Department, where he has been since 1994. He also currently serves as Chief Scientist of Guavus, Inc., a venture-backed company he co-founded with his graduate student. Professor Crovella also cofounded Commonwealth Networks, now part of Network Appliance.

“Mark has been a prolific academic entrepreneur but this past year was especially productive with the rapid growth of Guavus,” said Vinit Nijhawan (OTD Managing Director).

Professor Crovella’s research interests seek to improve understanding, design, and performance of parallel and networked computing through data mining, statistics, and performance evaluation.  In the networking arena, he has worked on characterizing the Internet and the World Wide Web.  He has explored the presence and implications of self-similarity and heavy-tailed distributions in the network traffic and Web workloads.  He has also investigated the implications of Web workloads for the design of scalable and cost-effective Web servers.  In addition he has made numerous contributions to the Internet measurement and modeling; and he has examined the impact of network properties on the design of protocols and the construction of statistical models.  As of 2013, Google Scholar reports over 19,000 citations of his work.

ParsonsfieldTDRR prides itself on finding great entertainment through live music that fosters socialization and networking. We welcomed the live music of Parsonsfield, formerly Poor Old Shine, an alternative americana band based in Mansfield, CT.

We’d like to thank this year’s  Tech, Drugs, and Rock n’ Roll sponsors:  Nixon Peabody, Pfizer, Sanofi US, Shore Chan DePumpo, and Wolf Greenfield.

Message from the Managing Director

OTD celebrated its 5th year of the Kindle Mentoring program, the Tech, Drugs and Rock ‘n Roll event and the Innovator of the Year award. In the past five years, OTD has generated record royalty licensing income. OTD has launched several venture-backed startups based on faculty research and inventions. Many of these were first gap-funded at BU and then went on to attract stellar management and private capital. Our unprecedented performance is directly attributed to the groundbreaking research undertaken by our faculty and the dedicated staff of OTD. Our goal over the next five years is to create a sustainable royalty licensing base, hopefully as the new ventures that we have launched bring their products to market.

We established an OTD External Advisory Board that met for the first time in February 2014 and will meet twice annually. The EAB is comprised of a combination of VC/investors, academic entrepreneur and CEO. The following figure shows the new OTD EAB:

advisory board pics

We have had little turnover in staff but in the competitive Boston ecosystem, a few of our people are moving on to: another technology transfer group (Jon Jensen to Partners RVL), a venture capital firm (April Effort to Third Rock Ventures) and leaving to do a startup (Renuka Babu). Ana Lopes has joined us to lead Physical Sciences BD (besides industry experience she was with MIT TLO). We are looking for a life sciences BD lead and a New Ventures leader. Please reach out to me if you are aware of suitable candidates.

Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs

Read the Xconomy article here to find out more information.

Innovator of the Year Award Announced

At our 5th annual networking event “Tech, Drugs, and Rock n’ Roll” Mark Crovella was named Innovator of the Year.  Read more about him, his work, and the award in a BostInno article here!

A Cleaner, Cheaper Way to Make Metals

A startup called Infinium promises to reduce a troubling source of carbon emissions.

Read more here.

Letter from Leonard Nimoy

Picture 1I’m writing to tell you about Project SEARCH, being run by Dr. Christopher Gill and a team of public health and engineering students at Boston University. They are trying to solve one of the fundamental problems in global public health: identification of children over Space and Time. Their approach is clever and simple: they are developing an iPho

ne app that identifies young children based on photographs of their ears. A tool like this could really make a difference in our efforts to support vaccine programs, HIV care, nutritional campaigns, and other efforts helping children in poorer countries.

I hope you will join me in supporting their work so that all children can live long and prosper!

http://proj.at/1nLK3wb 

You have my thanks.

Picture 2

Boston University’s Office of Technology Development hosts its fifth annual Tech, Drugs, and Rock n’ Roll conference

Boston, MA – On July 15th, 2014, the Office of Technology Development at Boston University will host its fifth annual networking conference entitled, Tech, Drugs, and Rock n’ Roll (TDRR), from 4-8pm at 775 Commonwealth Avenue. Registration for the conference opened on May 1st, 2014.

TDRR is a networking event designed to connect scientists and engineers with entrepreneurs, investors, and innovators. The event will showcase emerging technologies from Boston University’s research programs in the fields of life sciences, physical sciences, medical technology, new ventures, and student-based ventures. The event will also include participation from key translational research centers including the Evans Center – Affinity Research Collaboratives, Clinical and Translational Science Institute, Center for Regenerative Medicine, Wallace H. Coulter Translational Research Partnership, Boston Biomedical Innovation Center, Center for Future Technologies in Cancer Care, Engineering Product Innovation Center, Rafik B. Hariri Institute for Computing and Computational Science & Engineering, Fraunhofer Center for Manufacturing Innovation, BU Start-up Summer Camp, and several new ventures launching from Boston University.

This year TDRR is going digital and using an outside vendor, ePosterboards, to provide us with 44” flat screen TVs to display content from the research centers mentioned above.

The event prides itself on finding a great band every year to provide lively music and foster a dynamic atmosphere for networking. This year, TDRR welcomes the live music of Poor Old Shine, an alternative americana touring band based in Mansfield, CT.

At 5:30pm, Provost of Boston University Jean Morrison will announce the recipient of this year’s Innovator of the Year Award. This award seeks to highlight translational research at Boston University by recognizing an entrepreneurial faculty member who translates his/her world-class research into inventions and innovations that benefit humankind.

Immediately following, Provost Jean Morrison, the Innovator of the Year Award, and Managing Director of the Office of Technology Development Vinit Nijhawan will participate in a photo-op and press conference. Members of the media may receive a media pass to gain access to the photo-op and press conference.

The sponsors of this year’s Tech, Drugs, and Rock n’ Roll conference are Nixon Peabody LLP, Pfizer Inc., Sanofi US LLC, Shore Chan DePumpo LLP, and Wolf Greenfield PC.

For more information about the conference and registration, please visit www.bu.edu/otd/tdrr.

OTD official partner of the TTS North America: July 21-22 at Rutgers University

BU’s Office of Technology Development is an official Partner of the TTS Global Initiative and this year’s TTS North America forum, which is coming to the East Coast after last year’s edition at UCSF in Mission Bay, San Francisco.

Our office’s Managing Director Vinit Nijhawan has been a keynote speaker at previous editions of the TTS Global Initiative in Asia (ETPL Singapore) and Europe (Institut Pasteur, France), and we are pleased to offer our preferred access and discounted rates to the only North American edition of the TTS Global Initiative. Using the Partner Code EBO14.

Founded in 2007, TTS brings together Key Opinion Leaders from all of the critical stakeholders involved in healthcare innovation to accelerate translation of world-class life sciences and biomedical research from the lab to the patient and the market. TTS provides a unique platform for open, panel–led round-table discussion, debate and deliberation under the Chatham House rule.  No pitches, no PR, no presentations other than the keynotes; the forum is simply a focused discussion on finding the best opportunities, collaborations and ways forward.

Special discounted rates for BU network members using the Partner Code EBO14. http://www.ttsglobalinitiative.com/

Boston University Launches Pilot Crowdfunding Platform

Boston University is proud to announce the pilot launch of its first-ever community fundraising platform: BU Crowdfunding. Think of it as a BU-exclusive, University-supported Kickstarter or Indiegogo. It’s an easy-to-use tool to collect donations, offer incentives, and get the word out.

Groups and individuals affiliated with BU, including students, faculty, and staff, can create their own crowdfunding projects on the site and raise money for innovative creations, service trips, events, research, and other BU-specific ventures—anything that supports BU’s overall mission and improves the BU community, on campus and beyond.

The first research project is a unique Mobile App that allows BU Global Health researchers to use ear biometrics to identify patients in Africa and other under-resourced countries: https://crowdfunding.bu.edu/project/535fc66e09206557630dfe47.

B-BIC Grant Opportunity

The Boston Biomedical Innovation Center (B-BIC) is now accepting applications for PILOT and DRIVE grants, which support research and development of innovative devices, diagnostics, as well as therapeutics related to heart, lung, blood, and sleep. PILOT grants provide up to $50,000 for direct costs for one year, while DRIVE grants provide up to $200,000 for milestone achievements over 1½ to two years. Applicants are requested to contact their institutional site miner prior to submitting their application.

B-BIC is a grouping of academic centers, government, venture capital, non-profit organizations, and industry designed to accelerate translational research and the development of solutions that will have health, economic, and societal impact. B-BIC is one of three National Centers for Accelerated Innovations (NCAI) selected by the National Institution of Health to address the gap between discovery and invention, and commercialization.

PILOT grants support collaborative research projects that are in the early stages of pre-commercialization. This grant provides up to $50,000 for tasks that support proof of concept. That is, reproducibility experiments, testing of key elements, or early prototype development.

DRIVE grants provide investments in early-stage technologies for completion of activities that help demonstrate proof of value. This grant provides up to $200,000 for system level testing or complete prototype development. DRIVE projects also receive mentoring from a team of experts.

Both of these grants have an open call for applications; pre-proposals may be submitted at any time. For additional information please visit B-BIC.org